{
  "zip": "100071",
  "sector": "Healthcare",
  "fullTimeEmployees": 233,
  "longBusinessSummary": "Lotus Pharmaceuticals, Inc. develops, manufactures, and sells pharmaceuticals in the People's Republic of China. The company markets valsartan capsules under the Maixin name to treat hypertension; eye drops under the Muxin name to treat glaucoma; and Octreotide Acetate Injection solution under the Yipubishan name for treating gastric ulcers. It also offers Junxin branded Levofloxacin, an anti-bacterial drug for the treatment of mild, moderate, and severe infections caused by susceptible trains of the designated microorganisms in the conditions such as acute maxillary sinusitis, acute bacterial exacerbation of chronic bronchitis, community-acquired pneumonia, complicated and uncomplicated skin and skin structure infections, complicated and uncomplicated urinary tract infections, and acute pyelonephritis; and Nicergoline for Injection, an a-receptor blockage nerve system blood-brain medicine. The company's products under development include R-Bambuterol-Class 1 for the treatment of asthma; Gliclazide-controlled release tablets for the treatment of diabetes; Isosorbide Mononitrate-tablets for the treatment of cardiovascular-coronary artery; Verapamil Hydrochloride tablets for the treatment of cardiovascular-irregular angina; and Lovastatin tablets, Valsartan-controlled release tablets, and Hawthorn Flavonoids tablets for the treatment of cardiovascular-hyperlipemia. It also involves in retailing Western and traditional Chinese medications, and medical treatment equipment through 10 retail pharmacy locations; performing research and development, and lab testing projects for third parties; and leasing retail space to licensed physicians, and merchants in the retail pharmacies. The company sells its products through a nationwide sales network to hospitals, clinics, and drugs stores. Lotus Pharmaceuticals, Inc. is based in Beijing, the People's Republic of China.",
  "city": "Beijing",
  "phone": "86 10 6389 9868",
  "country": "China",
  "companyOfficers": [],
  "maxAge": 1,
  "address1": "16 Cheng Zhuang Road",
  "fax": "86 10 6389 9867",
  "industry": "Drug Manufacturersâ€”Specialty & Generic",
  "address2": "Feng Tai District",
  "previousClose": 0.015,
  "regularMarketOpen": 0.015,
  "twoHundredDayAverage": 0.009468849,
  "trailingAnnualDividendYield": null,
  "payoutRatio": 0,
  "volume24Hr": null,
  "regularMarketDayHigh": 0.015,
  "navPrice": null,
  "averageDailyVolume10Day": 65165,
  "totalAssets": null,
  "regularMarketPreviousClose": 0.015,
  "fiftyDayAverage": 0.009056061,
  "trailingAnnualDividendRate": null,
  "open": 0.015,
  "averageVolume10days": 65165,
  "expireDate": null,
  "yield": null,
  "algorithm": null,
  "dividendRate": null,
  "exDividendDate": null,
  "beta": 1.304096,
  "circulatingSupply": null,
  "startDate": null,
  "regularMarketDayLow": 0.0085,
  "priceHint": 4,
  "currency": "USD",
  "trailingPE": 0.24193548,
  "regularMarketVolume": 7410,
  "lastMarket": null,
  "maxSupply": null,
  "openInterest": null,
  "marketCap": 762169,
  "volumeAllCurrencies": null,
  "strikePrice": null,
  "averageVolume": 17013,
  "priceToSalesTrailing12Months": 0.010675982,
  "dayLow": 0.0085,
  "ask": 0,
  "ytdReturn": null,
  "askSize": 0,
  "volume": 7410,
  "fiftyTwoWeekHigh": 0.03,
  "forwardPE": null,
  "fromCurrency": null,
  "fiveYearAvgDividendYield": null,
  "fiftyTwoWeekLow": 0.0052,
  "bid": 0,
  "tradeable": false,
  "dividendYield": null,
  "bidSize": 0,
  "dayHigh": 0.015,
  "exchange": "PNK",
  "shortName": "LOTUS PHARMACEUTICALS INC",
  "longName": "Lotus Pharmaceuticals, Inc.",
  "exchangeTimezoneName": "America/New_York",
  "exchangeTimezoneShortName": "EST",
  "isEsgPopulated": false,
  "gmtOffSetMilliseconds": "-18000000",
  "underlyingSymbol": null,
  "quoteType": "EQUITY",
  "symbol": "LTUS",
  "underlyingExchangeSymbol": null,
  "headSymbol": null,
  "messageBoardId": "finmb_29394029",
  "uuid": "4372549e-7008-3e66-a9cb-ce9262af1a61",
  "market": "us_market",
  "annualHoldingsTurnover": null,
  "enterpriseToRevenue": 0.09,
  "beta3Year": null,
  "profitMargins": 0.024319999,
  "enterpriseToEbitda": 0.625,
  "52WeekChange": null,
  "morningStarRiskRating": null,
  "forwardEps": null,
  "revenueQuarterlyGrowth": null,
  "sharesOutstanding": 27816500,
  "fundInceptionDate": null,
  "annualReportExpenseRatio": null,
  "bookValue": 3.577,
  "sharesShort": null,
  "sharesPercentSharesOut": null,
  "fundFamily": null,
  "lastFiscalYearEnd": 1293753600,
  "heldPercentInstitutions": 0,
  "netIncomeToCommon": 1719226,
  "trailingEps": 0.062,
  "lastDividendValue": null,
  "SandP52WeekChange": null,
  "priceToBook": 0.0041934582,
  "heldPercentInsiders": 0,
  "nextFiscalYearEnd": 1356912000,
  "mostRecentQuarter": 1317340800,
  "shortRatio": null,
  "sharesShortPreviousMonthDate": null,
  "floatShares": null,
  "enterpriseValue": 6442051,
  "threeYearAverageReturn": null,
  "lastSplitDate": null,
  "lastSplitFactor": null,
  "legalType": null,
  "morningStarOverallRating": null,
  "earningsQuarterlyGrowth": -0.813,
  "dateShortInterest": null,
  "pegRatio": null,
  "lastCapGain": null,
  "shortPercentOfFloat": null,
  "sharesShortPriorMonth": null,
  "category": null,
  "fiveYearAverageReturn": null,
  "regularMarketPrice": 0.015,
  "logo_url": ""
}